Madrigal Pharmaceuticals, Inc. (MDGL)

CIK 1157601 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Madrigal Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Nov 3, 202610-Q0001628280-26-069145
Nov 3, 20268-K0001628280-26-069093
Sep 28, 20261440001950047-26-009840
Sep 11, 202640001628280-26-061581
Sep 11, 20261440001950047-26-009360
Sep 9, 20261440001628280-26-061190
Aug 20, 20261440001628280-26-058254
Aug 20, 202640001628280-26-058256
Aug 18, 202630001628280-26-057747
Aug 18, 202640001628280-26-057751
Aug 12, 20268-K0001628280-26-055962
Jul 30, 202610-Q0001628280-26-050845
Jul 30, 20268-K0001628280-26-050775
Jul 29, 2026SCHEDULE 13G/A0002012383-26-002902
Jul 20, 20261440001628280-26-048913
Jul 20, 202640001628280-26-048919
Jun 18, 202640001628280-26-044290
Jun 18, 202640001628280-26-044307
Jun 18, 202640001628280-26-044346
Jun 18, 202640001628280-26-044340
Jun 18, 202640001628280-26-044325
Jun 18, 202640001193125-26-275800
Jun 17, 20268-K0001104659-26-075130
Jun 17, 2026S-80001104659-26-075183
Jun 1, 202640001628280-26-039653